Abbisko Cayman Future Growth
Future criteria checks 2/6
Abbisko Cayman's earnings are forecast to decline at 2.3% per annum while its annual revenue is expected to grow at 42.5% per year. EPS is expected to decline by 12.1% per annum. Return on equity is forecast to be -62.7% in 3 years.
Key information
-2.3%
Earnings growth rate
-12.1%
EPS growth rate
| Biotechs earnings growth | 34.4% |
| Revenue growth rate | 42.5% |
| Future return on equity | -62.7% |
| Analyst coverage | Low |
| Last updated | 27 Mar 2024 |
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 311 | -795 | -323 | N/A | 4 |
| 12/31/2025 | 255 | -785 | -12 | N/A | 4 |
| 12/31/2024 | 168 | -517 | -176 | N/A | 3 |
| 12/31/2023 | 19 | -432 | N/A | N/A | N/A |
| 9/30/2023 | 19 | -457 | N/A | N/A | N/A |
| 6/30/2023 | 19 | -483 | -468 | -444 | N/A |
| 3/31/2023 | 10 | -489 | -417 | -394 | N/A |
| 12/31/2022 | N/A | -496 | -367 | -344 | N/A |
| 9/30/2022 | 11 | -1,075 | -289 | -270 | N/A |
| 6/30/2022 | 23 | -1,654 | -212 | -196 | N/A |
| 3/31/2022 | 23 | -1,797 | -219 | -204 | N/A |
| 12/31/2021 | 23 | -1,810 | -182 | -170 | N/A |
| 3/31/2021 | 7 | -774 | -130 | -125 | N/A |
| 12/31/2020 | N/A | -707 | -127 | -123 | N/A |
| 12/31/2019 | 4 | -134 | -86 | -83 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2256 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 2256 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 2256 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 2256's revenue (42.5% per year) is forecast to grow faster than the Hong Kong market (7.9% per year).
High Growth Revenue: 2256's revenue (42.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2256 is forecast to be unprofitable in 3 years.